Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cardiff Oncology Inc. (CRDF)

14.19   0.18 (1.28%) 10-01 09:22
Open: 14.71 Pre. Close: 14.01
High: 16 Low: 13.94
Volume: 5,134,588 Market Cap: 355M
Cardiff Oncology Inc., formerly Trovagene, Inc., is a clinical-stage biotechnology company. The Company is focused on developing treatment options for cancer patients. It is developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Its clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). Its programs include the development of onvansertib in a Phase-I b/2 study of onvansertib in combination with FOLFIRI/Avastin in mCRC; a Phase II study of onvansertib in combination with Zytiga (abiraterone)/prednisone in Zytiga-resistant mCRPC, and a Phase-II study of onvansertib in combination with decitabine in AML.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 15.263 - 15.324 15.324 - 15.388
Low: 11.879 - 11.93 11.93 - 11.983
Close: 14.638 - 14.746 14.746 - 14.857

Technical analysis

as of: 2020-09-30 4:40:09 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 17.80     One year: 20.79
Support: Support1: 8.60    Support2: 4.50
Resistance: Resistance1: 15.24    Resistance2: 17.80
Pivot: 9.08
Moving Average: MA(5): 12.07     MA(20): 8.51
MA(100): 5.12     MA(250):
MACD: MACD(12,26): 1.70     Signal(9): 1.08
Stochastic oscillator: %K(14,3): 93.48     %D(3): 89.03
RSI: RSI(14): 81.63
52-week: High: 15.24  Low: 0.70  Change(%): 762.0
Average Vol(K): 3-Month: 198794  10-Days: 855239

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CRDF has closed below upper band by 1.5%. Bollinger Bands are 342.1% wider than normal. The large width of the bands suggest high volatility as compared to CRDF's normal range. The bands have been in this wide range for 26 bars. This is a sign that the current trend might continue.

Headline News

Wed, 30 Sep 2020
How Will the Market React to Cardiff Oncology Inc (CRDF) Stock Getting a Bullish Rating - InvestorsObserver

Wed, 30 Sep 2020
Cardiff Oncology Inc. (NASDAQ:CRDF) Stock is Soaring, Here is Why - The Oracle Dispatch

Wed, 30 Sep 2020
Why buying the Cardiff Oncology, Inc. (NASDAQ:CRDF) Stock Today Might Make Sense - Stocks Register

Wed, 30 Sep 2020
Cardiff Oncology Inc. (CRDF) volume hits 4.39 million: A New Opening for Investors - News Daemon

Wed, 30 Sep 2020
A Lesson to Learn: Cardiff Oncology Inc. (CRDF) - The News Heater

Tue, 29 Sep 2020
Cardiff Oncology Inc. (CRDF) market price of $14.85 offers the impression of an exciting value play - The InvestChronicle

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 25
Shares Float (M) 16
% Held by Insiders 0.19
% Held by Institutions 11.40
Shares Short (K) 970
Shares Short P. Month (K) 446

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -6568.38
Return on Assets (ttm) -47.5
Return on Equity (ttm) -99.9
Qtrly Rev. Growth 11.2
Gross Profit (p.s.) -0.437
Sales Per Share 0.010
EBITDA (p.s.) -0.650
Qtrly Earnings Growth
Operating Cash Flow (M) -14
Levered Free Cash Flow (M) -8

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 1447.37
Price to Cash Flow -26.08

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.